Activity of novel lactone ketolide nafithromycin against multicentric invasive and non-invasive pneumococcal isolates collected in India

BACKGROUND: India is among the nations reporting substantial healthcare burden linked to pneumococcal infections. Nafithromycin is a novel lactone ketolide antibiotic, which recently entered Phase 3 development in India for the indication of community-acquired bacterial pneumonia (CABP). OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeraraghavan, Balaji, Varghese, Rosemol, Saigal, Karnika, Balasubramanian, S, Bai, P Sulochana Putli, Lal Y, Binesh, Neeravi, Ayyanraj, Baskar, Pavithra, Anandhan, Kavipriya, Kumar, C P Girish, Jayaraman, Yuvraj, Nag, Vijaya Lakshmi, Baveja, Sujata, J, Bhavana, Joshi, Shrikrishna A, Iyer, Ranganathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210042/
https://www.ncbi.nlm.nih.gov/pubmed/34223128
http://dx.doi.org/10.1093/jacamr/dlab066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210042/
https://www.ncbi.nlm.nih.gov/pubmed/34223128
http://dx.doi.org/10.1093/jacamr/dlab066

Ejemplares similares